Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NewGenIVF Group Ltd. (NIVFW:NASDAQ), powered by AI.
NewGenIVF Group Ltd. is currently trading at $0.03. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for NewGenIVF Group Ltd. on Alpha Lenz.
View NewGenIVF Group Ltd.'s valuation metrics on Alpha Lenz.
“NewGenIVF Group Ltd.'s ROE is 77.2%. Explore profitability and growth together.”
Ask for details →NewGenIVF Group Ltd. is a company involved in the healthcare sector, specifically focusing on fertility treatments and assisted reproductive technologies. The primary function of NewGenIVF Group Ltd. is to offer a range of fertility services aimed at helping individuals and couples achieve their dreams of parenthood. These services might include in vitro fertilization (IVF), fertility counseling, and diagnostic testing. Operating in a sector that intersects with healthcare innovation and biotechnology, NewGenIVF Group Ltd. plays a significant role in advancing reproductive medicine, utilizing the latest scientific advancements to enhance success rates and patient care. As part of the broader healthcare industry, the company contributes to the growing demand for fertility and reproductive health services, reflecting societal trends towards delayed parenthood and increased awareness of reproductive health issues. NewGenIVF Group Ltd. demonstrates how specialized healthcare services are becoming increasingly integrated into the broader medical and health sectors, addressing critical needs in society.
“NewGenIVF Group Ltd.'s ROE is 77.2%. Explore profitability and growth together.”
Ask for details →NewGenIVF Group Ltd. (ticker: NIVFW) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 76 employees.
The current price is $0.029 with a P/E ratio of -x and P/B of -x.
ROE is 77.23% and operating margin is -226.95%. Annual revenue is $5M.